non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients#826512ClinicalTrials.gov
• Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer#828988ClinicalTrials.gov
• Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients#830170ClinicalTrials.gov
• cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors#834443ClinicalTrials.gov
• Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients#683070ClinicalTrials.gov
• A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases#834778ClinicalTrials.gov
• Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer#160159ClinicalTrials.gov
• Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer#805055ClinicalTrials.gov
• Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer#812326ClinicalTrials.gov
• Atezolizumab + Chemotherapy in Older Patients With Lung Cancer in Japan#338827OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER#407717ClinicalTrials.gov
• Study of Nivolumab for Advanced Cancers in India#830161ClinicalTrials.gov
• Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer#208447ClinicalTrials.gov
• Metformin in Non Small Cell Lung Cancer (NSCLC)#18575ClinicalTrials.gov
• Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer#481754ClinicalTrials.gov
• Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer#828941ClinicalTrials.gov
• Lactobacillus Bifidobacterium V9(Kex02)Improving the Efficacy of Carilizumab Combined With Platinum in Non-small Cell Lung Cancer Patients#121369ClinicalTrials.gov
• Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland#143541ClinicalTrials.gov
• Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer#311132ClinicalTrials.gov
• Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.#432890ClinicalTrials.gov
• Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases#481763ClinicalTrials.gov
• Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer#806374ClinicalTrials.gov
• A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer#840079ClinicalTrials.gov
• Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer#841317ClinicalTrials.gov
• Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung Cancer#826585ClinicalTrials.gov
• Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer#184800ClinicalTrials.gov
• Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer#825830ClinicalTrials.gov
• SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer#18604ClinicalTrials.gov
• Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer#181771ClinicalTrials.gov
• Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy#252971ClinicalTrials.gov
• Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer#256875ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV#283104ClinicalTrials.gov
• Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer#311129ClinicalTrials.gov
• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)#414386ClinicalTrials.gov
• Nitroglycerin in Non-small Cell Lung Cancer#829159ClinicalTrials.gov
• A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer#830914ClinicalTrials.gov
• A Study of ARQ 197 in Combination With Erlotinib#835002ClinicalTrials.gov
• Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3#842001ClinicalTrials.gov
• A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)#268015ClinicalTrials.gov
• The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer#842142ClinicalTrials.gov
• Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer#804686ClinicalTrials.gov
• Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer#346924ClinicalTrials.gov
• A Beta-only IL-2 ImmunoTherapY Study#245502ClinicalTrials.gov
• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers#803305ClinicalTrials.gov
• S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer#830205ClinicalTrials.gov
• The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer#833648ClinicalTrials.gov
• Pembrolizumab + Idelalisib for Lung Cancer Study#307454ClinicalTrials.gov
• Bronchoscopic Cryo-Immunotherapy of Lung Cancer#369824ClinicalTrials.gov
• Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer#256895ClinicalTrials.gov
• Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (ELEPHAS-01)#623515ClinicalTrials.gov